A detailed history of Center For Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Center For Asset Management LLC holds 18,163 shares of GILD stock, worth $1.54 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
18,163
Previous 17,579 3.32%
Holding current value
$1.54 Million
Previous $1.29 Million 3.19%
% of portfolio
0.74%
Previous 1.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$63.15 - $72.88 $36,879 - $42,561
584 Added 3.32%
18,163 $1.25 Million
Q1 2024

Apr 25, 2024

BUY
$71.58 - $87.29 $14,530 - $17,719
203 Added 1.17%
17,579 $1.29 Million
Q4 2023

Jan 22, 2024

SELL
$73.27 - $83.09 $114,887 - $130,285
-1,568 Reduced 8.28%
17,376 $1.41 Million
Q3 2023

Oct 27, 2023

BUY
$73.94 - $80.67 $3,549 - $3,872
48 Added 0.25%
18,944 $1.42 Million
Q2 2023

Jul 24, 2023

BUY
$76.01 - $86.7 $628,526 - $716,922
8,269 Added 77.81%
18,896 $1.46 Million
Q1 2023

Apr 24, 2023

SELL
$77.31 - $88.08 $482,878 - $550,147
-6,246 Reduced 37.02%
10,627 $881,000
Q4 2022

Jan 23, 2023

SELL
$62.32 - $89.47 $70,670 - $101,458
-1,134 Reduced 6.3%
16,873 $0
Q3 2022

Oct 21, 2022

BUY
$59.54 - $68.01 $143,967 - $164,448
2,418 Added 15.51%
18,007 $1.11 Million
Q2 2022

Jul 20, 2022

BUY
$57.72 - $65.01 $452,697 - $509,873
7,843 Added 101.25%
15,589 $964,000
Q1 2022

Apr 26, 2022

BUY
$57.92 - $72.58 $239,499 - $300,118
4,135 Added 114.51%
7,746 $461,000
Q4 2021

Jan 12, 2022

BUY
$64.88 - $73.64 $234,281 - $265,914
3,611 New
3,611 $262,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $106B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Center For Asset Management LLC Portfolio

Follow Center For Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center For Asset Management LLC with notifications on news.